Related references
Note: Only part of the references are listed.Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K-pneumoniae
Spyros Pournaras et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates
Anthony M. Nicasio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
Sylvain Goutelle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Spread of Klebsiella pneumoniae Carbapenemases: A Tale of Strains, Plasmids, and Transposons
L. Silvia Munoz-Price et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem
Scott A. Weisenberg et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Leanne B. Gasink et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007)
Niels Norskov-Lauritsen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs
Jared L. Crandon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)
H. C. Maltezou et al.
JOURNAL OF INFECTION (2009)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
Luigi Principe et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2009)
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy
Ellen S. Moland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Isolation of imipenem-resistant Enterobacter species:: Emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes
Dror Marchaim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli
Raymond Cha
PHARMACOTHERAPY (2008)
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing enterobactefiaceae:: Report from the SENTRY antimicrobial surveillance program
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation
Christopher M. Rubino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumonide in Brooklyn, NY
David Landman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae
Michael W. Daly et al.
PHARMACOTHERAPY (2007)
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumanni
Marc H. Scheetz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial
Samir G. Sakka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections
S. A. Van Wart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients
Chonghua Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam
Maria E. Pachon-Ibanez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae
C. Andrew DeRyke et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections
Mireia Saballs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)
SK Bouchillon et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents
S Bratu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium
S Bratu et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline
JE Conte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
PA Bradford et al.
CLINICAL INFECTIOUS DISEASES (2004)
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model
A Montero et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin
JE Conte et al.
CLINICAL PHARMACOKINETICS (2004)
Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem
JL Kuti et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid
B Allegranzi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
